IMMUNE GLOBULIN NOS for Covid-19: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 83 adverse event reports in the FDA FAERS database where IMMUNE GLOBULIN NOS was used for Covid-19.
Most Reported Side Effects for IMMUNE GLOBULIN NOS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 963 | 42.8% | 228 | 533 |
| Off label use | 675 | 30.0% | 113 | 334 |
| Drug ineffective for unapproved indication | 266 | 11.8% | 69 | 143 |
| Condition aggravated | 207 | 9.2% | 31 | 138 |
| Product use in unapproved indication | 143 | 6.4% | 31 | 52 |
| Therapy non-responder | 130 | 5.8% | 14 | 82 |
| Treatment failure | 121 | 5.4% | 12 | 36 |
| Septic shock | 95 | 4.2% | 31 | 86 |
| Diarrhoea | 92 | 4.1% | 9 | 74 |
| Maternal exposure during pregnancy | 83 | 3.7% | 1 | 40 |
| Vomiting | 83 | 3.7% | 6 | 67 |
| Nausea | 81 | 3.6% | 4 | 54 |
| Drug intolerance | 77 | 3.4% | 1 | 67 |
| Disease progression | 67 | 3.0% | 14 | 22 |
| Intentional product use issue | 67 | 3.0% | 14 | 37 |
Other Indications for IMMUNE GLOBULIN NOS
Product used for unknown indication (292)
Immune thrombocytopenia (100)
Haemophagocytic lymphohistiocytosis (98)
Immunosuppressant drug therapy (98)
Dermatomyositis (92)
Myasthenia gravis (63)
Encephalitis autoimmune (52)
Interstitial lung disease (48)
Juvenile idiopathic arthritis (47)
Transplant rejection (43)
Other Drugs Used for Covid-19
REMDESIVIR (7,196)
HYDROXYCHLOROQUINE (5,280)
BAMLANIVIMAB (4,621)
NIRMATRELVIR\RITONAVIR (4,587)
TOCILIZUMAB (4,186)
DEXAMETHASONE (2,975)
CASIRIVIMAB\IMDEVIMAB (2,943)
SOTROVIMAB (2,732)
AZITHROMYCIN ANHYDROUS (2,510)
METHYLPREDNISOLONE (1,633)